As US FDA Shutdown Continues, What Will Be The Cost Of Not Spending?

Bolus of applications could be filed once government reopens, but employee morale and recruitment efforts could suffer drop-off.

Close-up of little On/Off switch with soft blurred background - Image

The partial shutdown of the US FDA that began Dec. 21 seems destined to continue at least a while longer, leaving sponsors unable to file applications and the agency unable to conduct inspections, among other stoppages.

The so-called "lapse period" (the second in 2018) began after Congress failed to pass an appropriations bill for FDA and...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Product Reviews

More from Pink Sheet